Regeneron Receivables Turnover vs Operating Margin Analysis

REGN Stock  USD 966.30  2.75  0.29%   
Trend analysis of Regeneron Pharmaceuticals balance sheet accounts such as Retained Earnings of 28.6 B, Cash of 2.9 B, Non Current Assets Total of 14.3 B or Non Currrent Assets Other of 466.3 M provides information on Regeneron Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Regeneron Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Regeneron Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.

About Regeneron Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Regeneron Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Regeneron Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Regeneron Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Regeneron currently owns. An asset can also be divided into two categories, current and non-current.

Regeneron Pharmaceuticals Balance Sheet Chart

Regeneron Pharmaceuticals Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Regeneron Pharmaceuticals uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Regeneron Pharmaceuticals' Non Current Assets Total are very stable compared to the past year. As of the 28th of March 2024, Non Currrent Assets Other is likely to grow to about 466.3 M, while Net Debt is likely to drop (28.5 M).

Total Assets

Total assets refers to the total amount of Regeneron Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Regeneron Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Regeneron Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Regeneron Pharmaceuticals are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.
Most indicators from Regeneron Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Regeneron Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.As of the 28th of March 2024, Selling General Administrative is likely to grow to about 2.7 B. Also, Tax Provision is likely to grow to about 584.1 M
 2021 2022 2023 2024 (projected)
Total Operating Expenses4.7B5.6B7.1B7.4B
Cost Of Revenue2.4B1.6B883.7M927.9M

Regeneron Pharmaceuticals fundamental ratios Correlations

0.971.00.94-0.060.990.970.93-0.240.960.980.150.950.32-0.660.970.980.830.930.940.980.580.990.930.980.58
0.970.960.94-0.030.950.990.84-0.310.980.980.20.950.45-0.660.990.990.730.960.880.990.650.970.830.980.56
1.00.960.93-0.090.990.950.94-0.250.950.960.130.920.28-0.670.950.970.850.910.960.960.550.990.940.970.56
0.940.940.93-0.160.890.930.87-0.150.910.940.310.960.37-0.440.960.930.680.860.830.950.670.970.810.960.78
-0.06-0.03-0.09-0.160.0-0.1-0.010.13-0.14-0.01-0.170.08-0.04-0.490.02-0.090.030.22-0.16-0.08-0.04-0.10.01-0.06-0.4
0.990.950.990.890.00.940.93-0.260.950.960.050.910.27-0.750.950.970.870.930.960.950.530.970.950.960.48
0.970.990.950.93-0.10.940.82-0.30.980.980.230.930.45-0.620.980.990.710.950.880.980.630.950.820.970.54
0.930.840.940.87-0.010.930.82-0.070.80.860.070.880.14-0.620.870.840.90.80.910.860.480.930.980.890.6
-0.24-0.31-0.25-0.150.13-0.26-0.3-0.07-0.39-0.2-0.05-0.06-0.370.26-0.19-0.32-0.4-0.26-0.26-0.220.01-0.22-0.15-0.23-0.01
0.960.980.950.91-0.140.950.980.8-0.390.970.180.890.41-0.630.950.990.730.920.910.970.580.950.820.950.5
0.980.980.960.94-0.010.960.980.86-0.20.970.220.970.33-0.650.990.990.710.960.890.980.620.970.850.970.56
0.150.20.130.31-0.170.050.230.07-0.050.180.220.280.270.370.240.19-0.070.170.050.210.230.2-0.020.160.47
0.950.950.920.960.080.910.930.88-0.060.890.970.280.37-0.590.990.930.670.940.810.960.690.950.830.960.65
0.320.450.280.37-0.040.270.450.14-0.370.410.330.270.37-0.130.420.390.120.430.140.450.690.290.120.430.24
-0.66-0.66-0.67-0.44-0.49-0.75-0.62-0.620.26-0.63-0.650.37-0.59-0.13-0.63-0.65-0.71-0.76-0.66-0.61-0.25-0.6-0.71-0.630.11
0.970.990.950.960.020.950.980.87-0.190.950.990.240.990.42-0.630.970.710.960.860.990.680.970.840.980.61
0.980.990.970.93-0.090.970.990.84-0.320.990.990.190.930.39-0.650.970.750.940.910.980.610.970.850.970.53
0.830.730.850.680.030.870.710.9-0.40.730.71-0.070.670.12-0.710.710.750.710.870.720.280.810.940.770.37
0.930.960.910.860.220.930.950.8-0.260.920.960.170.940.43-0.760.960.940.710.810.940.610.910.810.940.4
0.940.880.960.83-0.160.960.880.91-0.260.910.890.050.810.14-0.660.860.910.870.810.870.360.930.940.880.47
0.980.990.960.95-0.080.950.980.86-0.220.970.980.210.960.45-0.610.990.980.720.940.870.730.970.840.990.59
0.580.650.550.67-0.040.530.630.480.010.580.620.230.690.69-0.250.680.610.280.610.360.730.570.410.670.49
0.990.970.990.97-0.10.970.950.93-0.220.950.970.20.950.29-0.60.970.970.810.910.930.970.570.910.970.65
0.930.830.940.810.010.950.820.98-0.150.820.85-0.020.830.12-0.710.840.850.940.810.940.840.410.910.880.47
0.980.980.970.96-0.060.960.970.89-0.230.950.970.160.960.43-0.630.980.970.770.940.880.990.670.970.880.6
0.580.560.560.78-0.40.480.540.6-0.010.50.560.470.650.240.110.610.530.370.40.470.590.490.650.470.6
Click cells to compare fundamentals

Regeneron Pharmaceuticals Account Relationship Matchups

Regeneron Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets14.8B17.2B25.4B29.2B33.1B34.7B
Total Current Liabilities1.8B2.8B3.5B3.8B3.4B3.6B
Total Stockholder Equity11.1B11.0B18.8B22.7B26.0B27.3B
Property Plant And Equipment Net2.9B3.2B3.5B3.8B4.1B4.4B
Net Debt(903.9M)502M(185.9M)(404.5M)(27.1M)(28.5M)
Retained Earnings7.4B10.9B19.0B23.3B27.3B28.6B
Cash1.6B2.2B2.9B3.1B2.7B2.9B
Non Current Assets Total4.2B4.4B4.9B7.1B13.6B14.3B
Non Currrent Assets Other531.8M328.9M555.2M(4.7B)444.1M466.3M
Cash And Short Term Investments6.5B6.7B12.5B14.3B10.8B11.4B
Net Receivables2.7B4.1B6.0B5.3B5.7B6.0B
Common Stock Shares Outstanding114.6M115.1M112.2M113.5M113.7M75.4M
Liabilities And Stockholders Equity14.8B17.2B25.4B29.2B33.1B34.7B
Non Current Liabilities Total1.9B3.3B3.2B2.7B3.7B3.9B
Other Current Assets959.3M1.2B332.4M933M386.6M203.9M
Other Stockholder Equity3.7B102.9M(173.4M)(404M)(1.2B)(1.1B)
Total Liab3.7B6.1B6.7B6.6B7.1B7.5B
Total Current Assets10.6B12.8B20.5B22.1B19.5B20.5B
Short Long Term Debt Total713.9M2.7B2.7B2.7B2.7B2.8B
Other Current Liab781.1M122.4M1.7B2.0B2.4B2.5B
Accounts Payable418.1M475.5M564M589.2M606.6M636.9M
Property Plant And Equipment Gross2.9B3.2B4.9B5.4B6.1B6.4B
Accumulated Other Comprehensive Income21.1M29.3M(26.2M)(238.8M)(80.9M)(76.9M)
Short Term Investments1.6B1.4B2.8B4.6B8.1B8.5B
Inventory1.4B1.9B2.0B2.4B2.6B2.7B
Other Liab889M635.5M515.3M707.8M814.0M854.7M
Other Assets913.3M2.8B555.2M747.6M859.7M902.7M
Property Plant Equipment2.9B3.2B3.5B3.8B4.3B4.5B
Current Deferred Revenue591.7M577.7M442M547.7M458.9M481.8M
Net Tangible Assets11.1B11.0B18.8B21.7B25.0B26.3B
Retained Earnings Total Equity7.4B10.9B19.0B23.3B26.8B28.1B
Long Term Debt Total713.9M2.0B2.0B2.0B2.3B2.4B
Capital Surpluse4.4B6.7B8.1B9.9B11.4B12.0B
Long Term Investments3.3B3.1B6.8B6.6B5.4B3.3B

Currently Active Assets on Macroaxis

When determining whether Regeneron Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Regeneron Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Regeneron Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Regeneron Pharmaceuticals Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regeneron Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
To learn how to invest in Regeneron Stock, please use our How to Invest in Regeneron Pharmaceuticals guide.
Note that the Regeneron Pharmaceuticals information on this page should be used as a complementary analysis to other Regeneron Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Regeneron Stock analysis

When running Regeneron Pharmaceuticals' price analysis, check to measure Regeneron Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regeneron Pharmaceuticals is operating at the current time. Most of Regeneron Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Regeneron Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regeneron Pharmaceuticals' price. Additionally, you may evaluate how the addition of Regeneron Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Is Regeneron Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.03)
Earnings Share
34.78
Revenue Per Share
122.935
Quarterly Revenue Growth
0.006
Return On Assets
0.0849
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.